TrialNature medicine2024

Belantamab mafodotin, pomalidomide and dexamethasone in refractory multiple myeloma: a phase 1/2 trial.

Suzanne Trudel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.